The Recall Desk
HighFDA (Drugs)·D-0392-2026·Announced 2026-03-11

Semaglutide injection multi-dose vials recalled over lack of sterility assurance

New Life Pharma is recalling two lots of Semaglutide Injection 2 mg x 10 sterile multi-dose vials for lack of assurance of sterility.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: this is an FDA Class II recall of an injectable medicine whose sterility cannot be assured, with no injuries stated in the source.

Plain-English summary

New Life Pharma LLC is recalling Semaglutide Injection, 2 mg x 10, sterile multi-dose vial, prescription only, labelled for Nomida of Olathe, Kansas, NDC 84223-001-07. About 820 vials were distributed in Ohio. The FDA has classified this recall as Class II.

The recall was initiated for lack of assurance of sterility.

Affected product covers lot 241113 (expiry 11/30/2026) and lot 250103 (expiry 1/31/2027).

Patients and prescribers can identify affected product by the NDC, lot numbers and expiry dates above, and may contact New Life Pharma LLC for further information.

The recalled product

Product
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
Manufacturer
New Life Pharma LLC
Category
Drug — Injectable
Hazard
  • sterility-failure
  • infection-risk
  • injectable

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot 241113
  • Exp Date 11/30/2026 & Lot 250103
  • Exp Date 1/31/2027

Distribution

Distributed in 1 state:

  • OH

Related recalls

Same category